Skip to content
OpenAdvisories
High ICSMA-21-012-01 9 CVEs

SOOIL Dana Diabecare RS Products

Published Jan 12, 2021 · Updated Jan 12, 2021

Summary

Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.

Vulnerabilities 9

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu …

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, an information disclosure vulnerability in the co…

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump an…

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insuli…

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insuli…

  • Unscored —

    In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump an…

  • Unscored —

    SOOIL Developments CoLtd DiabecareRS, AnyDana-i ,AnyDana-A, communication protocol of the insulin pump & AnyDana-i,AnyD…

  • Unscored —

    SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and AnyDana-…

  • Unscored —

    SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its Any…

Revision history

  1. #1

    ICSMA-21-012-01 SOOIL Dana Diabecare RS

References